English | Español
Patient Daily | Feb 5, 2026

Sandbox approach proposed as new model for rare disease drug development
Patient Daily | Feb 5, 2026

Revolution Medicines remains independent after failed takeover talks with Merck
Patient Daily | Feb 5, 2026

Study finds tertiary treatment reduces antibiotic resistance transfer from reclaimed irrigation water
Patient Daily | Feb 5, 2026

Review highlights possible link between microplastics exposure and Parkinson’s disease mechanisms
Patient Daily | Feb 5, 2026

Canadian study finds no adverse effects from daily full-fat dairy consumption in overweight adults
Patient Daily | Feb 5, 2026

Study links high-iron environments to persistent but less damaging Pseudomonas lung infections
Patient Daily | Feb 5, 2026

Editorial discusses promise of GLP‑1 drugs for reducing deaths among people with serious mental illness
Patient Daily | Feb 5, 2026

Review finds links between gut microbiome changes and Alzheimer’s progression

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'